Postpartum Depression: Etiology, Treatment, and Consequences for Maternal Care

Postpartum depression (PPD) is a disabling condition that has recently shown an increase in prevalence, becoming an essential public health problem. This study is a qualitative review summarizing the most frequent risk factors associated with PPD, evaluating molecular aspects of PPD and current approaches to detect and prevent PPD. The most prevalent risk factors were detected in the areas of economic and social factors, obstetrical history, lifestyle, and history of mental illness. Research on the genetic basis for PPD has taken place in recent years to identify the genes responsible for establishing targeted therapeutic methods and understanding its pathogenesis. The most frequently studied candidate gene was the serotonin transporter gene (SERT) associated with PPD. Among biological studies, antidepressants and psychological interventions provided the most evidence of successful intervention. The obstetrician can serve an essential role in screening for and treating PPD. Postpartum women with risk factors should be screened using the Edinburgh Postnatal Depression Scale (EPDS), but, at the moment, there are no prevention programs in Europe. In conclusion, data from this review increase concerns among this vulnerable population and can be used to design a screening tool for high-risk pregnant women and create a prevention program.

• Publication year

  2024

• Venue

  Diagnostics

• Publication date

  2024-04-23

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3390/diagnostics14090865PMID 38732283PMCID 11083152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk Factors for Postpartum Depression

  2024influential reference
• Psychodynamic Psychotherapy for Postpartum Depression: A Systematic Review

  2023cited by this paper
• EEG coherence before and after giving birth.

  2023cited by this paper
• FDA approves first oral treatment for postpartum depression

  2023cited by this paper
• Prevalence of postpartum depression and its associated factors within a year after birth in Semey, Kazakhstan: A cross sectional study

  2022influential reference
• Comparative efficacy and acceptability of pharmacotherapies for postpartum depression: A systematic review and network meta-analysis

  2022cited by this paper
• Postpartum Depression and Its Biological Biomarkers

  2022cited by this paper
• Risk Factors of Postpartum Depression

  2022cited by this paper
• Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program.

  2022cited by this paper
• Prevalence and Risk Factors Associated with Postpartum Depression during the COVID-19 Pandemic: A Literature Review and Meta-Analysis

  2022cited by this paper
• Effect of Zuranolone vs Placebo in Postpartum Depression

  2021cited by this paper
• Depressed Motherhood: Prevalence and Covariates of Maternal Postpartum Depression among Urban Mothers in India.

  2021cited by this paper
• Mapping global prevalence of depression among postpartum women

  2021influential reference
• Multiple modifiable lifestyle factors and the risk of perinatal depression during pregnancy: Findings from the GUSTO cohort.

  2020cited by this paper
• Early identification of postpartum depression using demographic, clinical, and digital phenotyping

  2020cited by this paper
• Promising leads and pitfalls: a review of dietary supplements and hormone treatments to prevent postpartum blues and postpartum depression

  2020cited by this paper
• Is Postpartum Depression Different From Depression Occurring Outside of the Perinatal Period? A Review of the Evidence.

  2020cited by this paper
• Postpartum depression

  2020cited by this paper
• Postnatal depression and its association with adverse infant health outcomes in low- and middle-income countries: a systematic review and meta-analysis

  2020influential reference
• The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms

  2019cited by this paper
• Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development

  2019cited by this paper
• Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes

  2019cited by this paper
• Assessment of Postpartum Depression and Anxiety among Females Attending Primary Health Care Facilities in Qaliubeya Governorate, Egypt

  2019cited by this paper
• Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics.

  2019cited by this paper
• Pathophysiological mechanisms implicated in postpartum depression.

  2019cited by this paper
• Stress, female reproduction and pregnancy.

  2019cited by this paper
• THE NEUROENDOCRINOLOGICAL ASPECTS OF PREGNANCY AND POSTPARTUM DEPRESSION.

  2019cited by this paper
• Postpartum depression: new drug will be monitored at approved sites

  2019cited by this paper
• Genetic basis for postpartum depression

  2019influential reference
• Predictors of Postpartum Depression: A Comprehensive Review of the Last Decade of Evidence.

  2018cited by this paper
• Economic and Health Predictors of National Postpartum Depression Prevalence: A Systematic Review, Meta-analysis, and Meta-Regression of 291 Studies from 56 Countries

  2018influential reference
• Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.

  2018cited by this paper
• Is depression more likely following childbirth? A population-based study

  2018cited by this paper
• Thyroid peroxidase antibodies during early gestation and the subsequent risk of first-onset postpartum depression: A prospective cohort study.

  2018influential reference
• Postpartum depression risk factors: A narrative review

  2017cited by this paper
• The Obstetrician-Gynecologist's Role in Detecting, Preventing, and Treating Depression.

  2017cited by this paper
• Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway

  2017cited by this paper
• Feasibility of screening and prevalence of prenatal depression in an obstetric setting in Spain.

  2017cited by this paper
• The relationship between employment status and depression symptomatology among women at risk for postpartum depression

  2017cited by this paper
• The functioning of the hypothalamic-pituitary-adrenal (HPA) axis in postpartum depressive states: a systematic review

  2017cited by this paper
• Physiological changes in pregnancy

  2016cited by this paper
• Lower Serum Zinc and Higher CRP Strongly Predict Prenatal Depression and Physio-somatic Symptoms, Which All Together Predict Postnatal Depressive Symptoms

  2016cited by this paper
• Pregnancy leads to long-lasting changes in human brain structure

  2016cited by this paper
• Oxytocin course over pregnancy and postpartum period and the association with postpartum depressive symptoms

  2016cited by this paper
• Elevated levels of Hs-CRP and IL-6 after delivery are associated with depression during the 6 months post partum.

  2016influential reference
• Postpartum Depression.

  2016cited by this paper
• Using the Patient Health Questionnaire (PHQ-9) and the Edinburgh Postnatal Depression Scale (EPDS) to assess suicidal ideation among pregnant women in Lima, Peru

  2015cited by this paper
• Is Postpartum Depression a Distinct Disorder?

  2015cited by this paper
• Heritability of Perinatal Depression and Genetic Overlap With Nonperinatal Depression.

  2015influential reference
• Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy

  2015cited by this paper
• Long-range neural synchrony in behavior.

  2015cited by this paper
• Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry.

  2015cited by this paper
• The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression.

  2015cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 5th ed.

  2014influential reference
• Diurnal cortisol patterns and psychiatric symptoms in pregnancy: short-term longitudinal study.

  2014cited by this paper
• Validation of the Edinburgh Postnatal Depression Scale as a screening tool for postpartum depression in a clinical sample in Hungary.

  2014cited by this paper
• Antidepressant treatment for postnatal depression.

  2014cited by this paper
• Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials.

  2014cited by this paper
• Early identification of women at risk of postpartum depression using the Edinburgh Postnatal Depression Scale (EPDS) in a sample of Lebanese women

  2014cited by this paper
• Prevalence and risk factors for postpartum depressive symptoms in Argentina: a cross-sectional study

  2013cited by this paper
• Thyroid function tests at delivery and risk for postpartum depressive symptoms.

  2013cited by this paper
• Postpartum depression symptoms associated with Val158Met COMT polymorphism

  2013cited by this paper
• Association study of the estrogen receptor gene ESR1 with postpartum depression—a pilot study

  2013cited by this paper
• Association of a serotonin transporter gene polymorphism (5-HTTLPR) and stressful life events with postpartum depressive symptoms: a population-based study

  2013cited by this paper
• Management of postpartum depression.

  2013cited by this paper
• Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice.

  2012cited by this paper
• Postpartum depression: diagnostic and treatment issues.

  2012influential reference
• Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: a systematic review.

  2012cited by this paper
• Depression as a disease of modernity: explanations for increasing prevalence.

  2012cited by this paper
• Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.

  2012cited by this paper
• Postpartum Depression: A Review

  2012influential reference
• A longitudinal study of postpartum depressive symptoms: multilevel growth curve analyses of emotion regulation strategies, breastfeeding self-efficacy, and social support

  2012cited by this paper
• Employment, income, and education and risk of postpartum depression: the Osaka Maternal and Child Health Study.

  2011cited by this paper
• Postpartum depression symptoms: a case–control study on monoaminergic functional polymorphisms and environmental stressors

  2011cited by this paper
• Postpartum mental health screening and diagnosis by obstetrician–gynecologists

  2011cited by this paper
• Endocrine induced changes in brain function during pregnancy.

  2010cited by this paper
• Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.

  2010cited by this paper
• Violence against women by their intimate partner during pregnancy and postnatal depression: a prospective cohort study.

  2010cited by this paper
• Thyroid function 48h after delivery as a marker for subsequent postpartum depression.

  2010cited by this paper
• Postpartum depression: an original survey of screening practices within a healthcare system

  2010cited by this paper
• Postpartum depression.

  2009cited by this paper
• Genome-wide linkage and follow-up association study of postpartum mood symptoms.

  2009influential reference
• Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care

  2009cited by this paper
• Postpartum Depression: An Update

  2009cited by this paper
• Identification of Postpartum Depression

  2009influential reference
• The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT.

  2009cited by this paper
• Postpartum depression: what we know.

  2009cited by this paper
• Symptoms of Postpartum Depression Associated With Elevated Levels of Interleukin-1 Beta During the First Month Postpartum

  2008cited by this paper
• The Psychoneuroimmunology of Postpartum Depression

  2008cited by this paper
• Adaptive Responses of the Maternal Hypothalamic‐Pituitary‐Adrenal Axis during Pregnancy and Lactation

  2008cited by this paper
• Mood changes after delivery: role of the serotonin transporter gene

  2008cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2008cited by this paper
• Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study.

  2008cited by this paper
• The Use of Electroconvulsive Therapy in Postpartum Affective Disorders

  2007cited by this paper
• Physiological changes in pregnancy

  2007cited by this paper
• Depression symptom prevalence and demographic risk factors among U.S. women during the first 2 years postpartum.

  2007cited by this paper
• A new paradigm for depression in new mothers: the central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health

  2007cited by this paper
• New parents and mental disorders: a population-based register study.

  2006cited by this paper
• Use of Psychotropic Medications in Treating Mood Disorders during Lactation

  2006cited by this paper
• Perinatal Depression: A Systematic Review of Prevalence and Incidence

  2005influential reference

• Cognitive Behavioral Therapy for Insomnia in Postpartum Depression: A Meta-Analysis of Therapeutic Outcomes and Barriers to Clinical Use.

  2026cites this paper
• Repérage de la dépression du post-partum

  2026cites this paper
• The Correlation of Postpartum Depression, Breastfeeding Prevalence, and Milk Production in NICU

  2025cites this paper
• Estrogenic Effect of Probiotics on Anxiety and Depression: A Narrative Review

  2025cites this paper
• Multimodal large language models for women’s reproductive mental health

  2025cites this paper
• Research Progress on the Current Status and Influencing Factors of Perinatal Depression in Cesarean Section

  2025cites this paper
• Killing of sons and daughters: a systematic review for analysing the elements to distinguish the different features and circumstances related to these filicides

  2025cites this paper
• Selected Lipidome Components and Their Association with Perinatal Depression

  2025cites this paper
• Preventing postpartum depression through pre-delivery screening and targeted interventions

  2025cites this paper
• Comparative Effectiveness of Non-Pharmacological Interventions for Postpartum Depression and Anxiety: A Network Meta-Analysis

  2025cites this paper
• Is an improvement in anaemia and iron levels associated with the risk of early postpartum depression? A cohort study from Lagos, Nigeria

  2025cites this paper
• Intrapartum Synthetic Oxytocin as a Potential Mediator for Postpartum Depression

  2025cites this paper
• Ultrasound-guided stellate ganglion block with ropivacaine for postpartum depression.

  2025cites this paper
• Perinatal mental health care goes digital: Opportunities for digital health to revolutionize the care delivery for healthier pregnancies and outcomes

  2025cites this paper
• Suffering in silence: Accessing mental health care and repetitive transcranial magnetic stimulation (rTMS) for peripartum depression - A qualitative study

  2025cites this paper
• Perinatal depression, perinatal mental health, and legal interventions: a medico-legal anthropological concept

  2025cites this paper
• Prevalence, risk factors and family dynamics of antenatal depression in couples: A multicenter cross-sectional study.

  2025cites this paper
• Exploring the feasibility and acceptability of using fMRI to measure pain responses in women with and without postpartum depression.

  2025cites this paper
• Navigating Therapies, Challenges, and Recommendations for Treatment-Resistant Peripartum Depression: A Comprehensive Review

  2025cites this paper
• The masking effects of self-efficacy and marital satisfaction on the association between childhood trauma and postpartum depressive symptoms: a cross-sectional study

  2025cites this paper
• Early Postpartum Screening: Predictive Value of Edinburgh Postnatal Depression Scale (EPDS) Scores on Day 3 for Depression at One Month

  2025cites this paper
• The Efficacy of Benson Relaxation for Managing Psychological Distress in Primipostpartum Women: A Systematic Review

  2024cites this paper
• Understanding and Addressing Male Postpartum Depression: Incidence, Causes, Diagnosis, and Management Strategies

  2024cites this paper
• Doğum Sonrası Depresyon Endikasyonu Onaylı İlaçlar: Breksanolon ve Zuranolon

  2024cites this paper
• Advances in Psychotropic Treatment for Pregnant Women: Efficacy, Adverse Outcomes, and Therapeutic Monitoring

  2024cites this paper
• Creative art therapy for postpartum depression： A systematic review and meta-analysis.

  2024cites this paper
• From Breastfeeding to Support in Mothers’ Feeding Choices: A Key Role in the Prevention of Postpartum Depression?

  2024cites this paper
• The association between family relationships and depressive symptoms among pregnant women: A network analysis

  2022cites this paper